Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
about
Efficacy of zolmitriptan nasal spray in management of acute migraineSystematic Review of Preventive and Acute Treatment of Menstrual Migraine.Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative studyA review of the use of frovatriptan in the treatment of menstrually related migraine.Almotriptan for menstrually related migraine.Triptans: over the migraine.Treatment of perimenstrual migraine with triptans: an update.Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.Comparative tolerability of treatments for acute migraine: A network meta-analysis.Triptans and migraine: advances in use, administration, formulation, and development.Menstrual Migraine and Treatment Options: Review.Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.Menstrual migraine: a review of current and developing pharmacotherapies for women.Pharmacokinetic evaluation of almotriptan for the treatment of migraines.Treatment strategies for menstrually related migraine.
P2860
Q33979686-4C201518-E53B-467E-9078-999ADC8EA65AQ35742998-A9782D29-C6E9-4D01-A9B1-64DA37F7121AQ36052155-D9A748D5-B30C-4EC9-AF44-C455CF02B161Q36638660-83392D27-E922-424C-917E-C4AE68A1FE01Q37897224-9F0C855C-539D-42F2-9153-6C2C433AE735Q38014303-66618D1C-ED00-4115-AE3D-A24445FE9B9DQ38014363-CB2847BA-EFB7-407F-A33D-157C52703989Q38237616-3A3A762E-645C-4C35-ABEF-2ED2C40A8D66Q38927015-50AF5106-03B9-456E-8377-8F72A089D287Q38994955-A1967241-E64D-4097-B6B8-9F2840E39D75Q39026779-6275A342-A56D-42F8-9AC3-84388213DDF8Q45995793-66DD8677-9EEC-4998-9C5B-096F172DC661Q50047547-B595AA5C-1DBE-42A1-960D-7825C3ED739FQ50490563-AE47818E-935D-45BC-BB0B-DAA8F84171C8Q51314345-61D9FD42-D704-41B9-A5EF-1FF19426709D
P2860
Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@ast
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@en
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@nl
type
label
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@ast
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@en
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@nl
prefLabel
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@ast
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@en
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Almotriptan 12.5 mg in menstru ...... ind, placebo-controlled study.
@en
P2093
Fabio Valguarnera
Florindo d'Onofrio
Franca Moschiano
Gian Camillo Manzoni
Giancarlo Acuto
Giovanni D'Andrea
Rita Allais
P2860
P304
P356
10.1177/0333102410378048
P407
P577
2010-07-26T00:00:00Z